{"database": "lobbying", "table": "lobbying_activities", "rows": [[2503981, "12c11c87-aa4b-4691-95fb-80172ab11942", "Q3", "WATKINS & EAGER PLLC", 401104403, "ZYNERBA PHARMACEUTICALS, INC.", 2020, "third_quarter", "HCR", "Assist in the development & approval process before the FDA of Zynerba's lead therapeutic for the potential treatment of behavioral symptoms associated with Fragile X Syndrome.", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2020-10-05T13:28:00.437000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2503981"], "units": {}, "query_ms": 5.69628702942282, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}